Ethyl Acetate

Ethyl Acetate

SCHEMBL1821708

CCOC(C)=O.CCOC(C)C

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
LMNA P02545 2/20 0.67
HSD17B10 Q99714 1/20 0.67
TSHR P16473 2/20 0.43
ALOX15 P16050 2/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
HPGD P15428 1/20 0.37
TRPA1 O75762 1/20 0.36
GLO1 Q04760 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
THRB P10828 1/20 0.33
PGR P06401 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
HTR1A P08908 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL2372229 0.86 ALDH1A1 (0.67) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL9468886 0.86 ALDH1A1 (0.67) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL4329077 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL6953852 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL27497305 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL81216 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL4208051 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL10332976 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL6722629 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL2874587 0.83 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703912-B2 Processes for removal of dibenzofulvene AJINOMOTO CO., INC. (JP) 2014-04-22 US disclosed
EP-2322498-B1 PROCESSES FOR REMOVING DIBENZOFULVENE AJINOMOTO KK (JP) 2014-04-16 EP disclosed
US-20110190475-A1 PROCESSES FOR REMOVAL OF DIBENZOFULVENE AJINOMOTO CO., INC. (JP) 2011-08-04 US disclosed
EP-2322498-A1 PROCESSES FOR REMOVING DIBENZOFULVENE Ajinomoto Co., Inc. (JP) 2011-05-18 EP disclosed
US-4024120-A ETHYL ACETATE, ALCOHOL, WATER MILES LABORATORIES, INC. (US) 1977-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190475-A1 PROCESSES FOR REMOVAL OF DIBENZOFULVENE DDC, DNPEP, DAO ALDH1A1 4227/4885LMNA 3096/4885HSD17B10 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.